Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease (Q33666297)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease |
scientific article |
Statements
1 reference
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease (English)
1 reference
John Q Trojanowski
1 reference
Karl Kieburtz
1 reference
Andrew Siderowf
1 reference
Caroline M Tanner
1 reference
Brit Mollenhauer
1 reference
Andrew Singleton
1 reference
Tanya Simuni
1 reference
Leslie M Shaw
1 reference
Kenneth Marek
1 reference
Mark Frasier
1 reference
Danna Jennings
1 reference
Sarah Pan
1 reference
Teresa Waligórska
1 reference
Alice S Chen-Plotkin
1 reference
Ju-Hee Kang
1 reference
David J Irwin
1 reference
Chelsea Caspell
1 reference
Christopher S Coffey
1 reference
Peggy Taylor
1 reference
Sohini Chowdhury
1 reference
Parkinson's Progression Markers Initiative
1 reference
1 October 2013
1 reference
1 reference
70
1 reference
10
1 reference
1277-1287
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference